Analysis of the regulatory and catalytic domains of PTEN-induced kinase-1 (PINK1)

Human Mutation

Volumn 33, Issue 10, 2012, Pages 1408-1422

  Sim, Chou Hung ^a   Gabriel, Kipros ^b   Mills, Ryan D ^a   Culvenor, Janetta G ^c   Cheng, Heung Chin ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Mitochondrial dysfunction; Mitochondrial proteases; Neuronal survival; Parkinson disease; Protein kinase

Indexed keywords

PEPTIDASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEINASE;

BIOCHEMISTRY; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CONCEPTUAL FRAMEWORK; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SPECIFICITY; GENE; GENE MUTATION; HUMAN; MITOCHONDRIAL TARGETING SIGNAL; NEUROPROTECTION; NONHUMAN; PHOSPHATASE AND TENSIN HOMOLOG INDUCED KINASE 1 GENE; PREDICTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; REVIEW; STRUCTURAL BIOINFORMATICS;

ANIMALS; CATALYTIC DOMAIN; HUMANS; MITOCHONDRIA; PARKINSON DISEASE; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; SUBSTRATE SPECIFICITY;

EID: 84866283918     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22127     Document Type: Review

References (106)

1. Allison DS, Schatz G. 1986. Artificial mitochondrial presequences. Proc Natl Acad Sci U S A 83:9011-9015.
2. Beasley EM, Muller S, Schatz G. 1993. The signal that sorts yeast cytochrome b2 to the mitochondrial intermembrane space contains three distinct functional regions. EMBO J 12:2303-2311.
3. Becker D, Richter J, Tocilescu MA, Przedborski S, Voos W. 2012. Pink1 and its Δ ψ-dependent cleavage product both localize to the outer mitochondrial membrane by a unique targeting mode. J Biol Chem online April 30, 2012; doi: 10.1074/jbc.M112.365700.
4. Beilina A, Van Der Brug M, Ahmad R, Kesavapany S, Miller DW, Petsko GA, Cookson MR. 2005. Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci U S A 102:5703-5708.
5. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. 1973. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415-455.
6. Brinkworth RI, Breinl RA, Kobe B. 2003. Structural basis and prediction of substrate specificity in protein serine/threonine kinases. Proc Natl Acad Sci U S A 100:74-79.
7. Cardona F, Sanchez-Mut JV, Dopazo H, Perez-Tur J. 2011. Phylogenetic and in silico structural analysis of the Parkinson disease-related kinase PINK1. Hum Mutat 32:369-378.
8. Chao LH, Pellicena P, Deindl S, Barclay LA, Schulman H, Kuriyan J. 2010. Intersubunit capture of regulatory segments is a component of cooperative CaMKII activation. Nat Struct Mol Biol 17:264-272.
9. Cheng HC, Kemp BE, Pearson RB, Smith AJ, Misconi L, Van Patten SM, Walsh DA. 1986. A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem 261:989-992.
10. Chu CT. 2010. Tickled PINK1: mitochondrial homeostasis and autophagy in recessive Parkinsonism. Biochim Biophys Acta 1802:20-28.
11. Claros MG, von Heijne G. 1994. TopPred II: an improved software for membrane protein structure predictions. Comput Appl Biosci 10:685-686.
12. Cohen P, Knebel A. 2006. KESTREL: a powerful method for identifying the physiological substrates of protein kinases. Biochem J 393:1-6.
13. Corti O, Lesage S, Brice A. 2011. What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol Rev 91:1161-1218.
14. De Bondt HL, Rosenblatt J, Jancarik J, Jones HD, Morgan DO, Kim SH. 1993. Crystal structure of cyclin-dependent kinase 2. Nature 363:595-602.
15. Deas E, Plun-Favreau H, Gandhi S, Desmond H, Kjaer S, Loh SH, Renton AE, Harvey RJ, Whitworth AJ, Martins LM, Abramov AY, Wood NW. 2011a. PINK1 cleavage at position A103 by the mitochondrial protease PARL. Hum Mol Genet 20:867-879.
16. Deas E, Wood NW, Plun-Favreau H. 2011b. Mitophagy and Parkinson's disease: the PINK1-parkin link. Biochim Biophys Acta 1813:623-633.
17. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661-665.
18. Ellis JJ, Kobe B. 2011. Predicting protein kinase specificity: Predikin update and performance in the DREAM4 challenge. PLoS One 6:e21169.
19. Emanuelsson O, von Heijne G. 2001. Prediction of organellar targeting signals. Biochim Biophys Acta 1541:114-119.
20. Emanuelsson O, von Heijne G, Schneider G. 2001. Analysis and prediction of mitochondrial targeting peptides. Methods Cell Biol 65:175-187.
21. Fung HC, Chen CM, Hardy J, Singleton AB, Lee-Chen GJ, Wu YR. 2006. Analysis of the PINK1 gene in a cohort of patients with sporadic early-onset parkinsonism in Taiwan. Neurosci Lett 394:33-36.
22. Gabriel K, Pfanner N. 2007. The mitochondrial machinery for import of precursor proteins. Methods Mol Biol 390:99-117.
23. Gakh O, Cavadini P, Isaya G. 2002. Mitochondrial processing peptidases. Biochim Biophys Acta 1592:63-77.
24. Gandhi S, Muqit MM, Stanyer L, Healy DG, Abou-Sleiman PM, Hargreaves I, Heales S, Ganguly M, Parsons L, Lees AJ, Latchman DS, Holton JL, Wood NW, Revesz T. 2006. PINK1 protein in normal human brain and Parkinson's disease. Brain 129:1720-1731.
25. Gandhi S, Wood-Kaczmar A, Yao Z, Plun-Favreau H, Deas E, Klupsch K, Downward J, Latchman DS, Tabrizi SJ, Wood NW, Duchen MR, Abramov AY. 2009. PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell 33:627-638.
26. Gavel Y, von Heijne G. 1990. Cleavage-site motifs in mitochondrial targeting peptides. Protein Eng 4:33-37.
27. Greene AW, Grenier K, Aguileta MA, Muise S, Farazifard R, Haque ME, McBride HM, Park DS, Fon EA. 2012. Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep 13:378-385.
28. Hanks SK, Hunter T. 1995. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 9:576-596.
29. Haque ME, Thomas KJ, D'Souza C, Callaghan S, Kitada T, Slack RS, Fraser P, Cookson MR, Tandon A, Park DS. 2008. Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc Natl Acad Sci U S A 105:1716-1721.
30. Hartl FU, Ostermann J, Guiard B, Neupert W. 1987. Successive translocation into and out of the mitochondrial matrix: targeting of proteins to the intermembrane space by a bipartite signal peptide. Cell 51:1027-1037.
31. Hughes AJ, Daniel SE, Kilford L, Lees AJ. 1992. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184.
32. Ia KK, Jeschke GR, Deng Y, Kamaruddin MA, Williamson NA, Scanlon DB, Culvenor JG, Hossain MI, Purcell AW, Liu S, Zhu HJ, Catimel B, Turk BE, Cheng HC. 2011. Defining the substrate specificity determinants recognized by the active site of C-terminal Src kinase-homologous kinase (CHK) and identification of beta-synuclein as a potential CHK physiological substrate. Biochemistry 50:6667-6677.
33. Imai Y, Kanao T, Sawada T, Kobayashi Y, Moriwaki Y, Ishida Y, Takeda K, Ichijo H, Lu B, Takahashi R. 2010. The loss of PGAM5 suppresses the mitochondrial degeneration caused by inactivation of PINK1 in Drosophila. PLoS Genet 6:e1001229.
34. Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, Massague J, Pavletich NP. 1995. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376:313-320.
35. Jensen RE, Schmidt S, Mark RJ. 1992. Mutations in a 19-amino-acid hydrophobic region of the yeast cytochrome c1 presequence prevent sorting to the mitochondrial intermembrane space. Mol Cell Biol 12:4677-4686.
36. Jiang JH, Davies JK, Lithgow T, Strugnell RA, Gabriel K. 2011. Targeting of Neisserial PorB to the mitochondrial outer membrane: an insight on the evolution of beta-barrel protein assembly machines. Mol Microbiol 82:976-987.
37. Jin SM, Lazarou M, Wang C, Kane LA, Narendra DP, Youle RJ. 2010. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol 191:933-942.
38. Jin SM, Youle RJ. 2012. PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci 125:795-799.
39. Johnson DA, Akamine P, Radzio-Andzelm E, Madhusudan M, Taylor SS. 2001. Dynamics of cAMP-dependent protein kinase. Chem Rev 101:2243-2270.
40. Knowles PP, Murray-Rust J, Kjaer S, Scott RP, Hanrahan S, Santoro M, Ibanez CF, McDonald NQ. 2006. Structure and chemical inhibition of the RET tyrosine kinase domain. J Biol Chem 281:33577-33587.
41. Lazarou M, Jin SM, Kane LA, Youle RJ. 2012. Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. Dev Cell 22:320-333.
42. Lin W, Kang UJ. 2008. Characterization of PINK1 processing, stability, and subcellular localization. J Neurochem 106:464-474.
43. Lu B. 2009. Mitochondrial dynamics and neurodegeneration. Curr Neurol Neurosci Rep 9:212-219.
44. Martin I, Dawson VL, Dawson TM. 2011. Recent advances in the genetics of Parkinson's disease. Annu Rev Genomics Hum Genet 12:301-325.
45. Matenia D, Hempp C, Timm T, Eikhof A, Mandelkow EM. 2012. Microtubule affinity-regulating kinase 2 (MARK2) turns on phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1) at Thr-313, a mutation site in Parkinson disease: effects on mitochondrial transport. J Biol Chem 287:8174-8186.
46. Meissner C, Lorenz H, Weihofen A, Selkoe DJ, Lemberg MK. 2011. The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. J Neurochem 117:856-867.
47. Michiorri S, Gelmetti V, Giarda E, Lombardi F, Romano F, Marongiu R, Nerini-Molteni S, Sale P, Vago R, Arena G, Torosantucci L, Cassina L, et al. 2010. The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ 17:962-974.
48. Mills RD, Sim CH, Mok SS, Mulhern TD, Culvenor JG, Cheng HC. 2008. Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1). J Neurochem 105:18-33.
49. Mok J, Kim PM, Lam HY, Piccirillo S, Zhou X, Jeschke GR, Sheridan DL, Parker SA, Desai V, Jwa M, Cameroni E, Niu H, et al. 2010. Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifs. Sci Signal 3:ra12.
50. Mologni L, Rostagno R, Brussolo S, Knowles PP, Kjaer S, Murray-Rust J, Rosso E, Zambon A, Scapozza L, McDonald NQ, Lucchini V, Gambacorti-Passerini C. 2010. Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors. Bioorg Med Chem 18:1482-1496.
51. Muqit MM, Abou-Sleiman PM, Saurin AT, Harvey K, Gandhi S, Deas E, Eaton S, Payne Smith MD, Venner K, Matilla A, Healy DG, Gilks WP, et al. 2006. Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J Neurochem 98:156-169.
52. Murata H, Sakaguchi M, Jin Y, Sakaguchi Y, Futami J, Yamada H, Kataoka K, Huh NH. 2011. A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2. J Biol Chem 286:7182-7189.
53. Narayana N, Cox S, Shaltiel S, Taylor SS, Xuong N. 1997. Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine. Biochemistry 36:4438-4448.
54. Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, Youle RJ. 2010. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8:e1000298.
55. Nguyen M, Bell AW, Shore GC. 1988. Protein sorting between mitochondrial membranes specified by position of the stop-transfer domain. J Cell Biol 106:1499-1505.
56. Niefind K, Guerra B, Pinna LA, Issinger OG, Schomburg D. 1998. Crystal structure of the catalytic subunit of protein kinase CK2 from Zea mays at 2.1 A resolution. EMBO J 17:2451-2462.
57. Nolen B, Yun CY, Wong CF, McCammon JA, Fu XD, Ghosh G. 2001. The structure of Sky1p reveals a novel mechanism for constitutive activity. Nat Struct Biol 8:176-183.
58. Pearson RB, Kemp BE. 1991. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol 200:62-81.
59. Pellegrini L, Scorrano L. 2007. A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis. Cell Death Differ 14:1275-1284.
60. Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, Scheid M, Chen F, Gu Y, Hasegawa H, Salehi-Rad S, Wang L, Rogaeva E, et al. 2005. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem 280:34025-34032.
61. Pfanner N, Truscott KN. 2002. Powering mitochondrial protein import. Nat Struct Biol 9:234-236.
62. Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D, Harvey K, Deas E, Harvey RJ, McDonald N, Wood NW, Martins LM, Downward J. 2007. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol 9:1243-1252.
63. Poole AC, Thomas RE, Yu S, Vincow ES, Pallanck L. 2010. The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. PLoS One 5:e10054.
64. Prakash S, Matouschek A. 2004. Protein unfolding in the cell. Trends Biochem Sci 29:593-600.
65. Pridgeon JW, Olzmann JA, Chin LS, Li L. 2007. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5:e172.
66. Rafie-Kolpin M, Chefalo PJ, Hussain Z, Hahn J, Uma S, Matts RL, Chen JJ. 2000. Two heme-binding domains of heme-regulated eukaryotic initiation factor-2alpha kinase. N terminus and kinase insertion. J Biol Chem 275:5171-5178.
67. Rakovic A, Grunewald A, Seibler P, Ramirez A, Kock N, Orolicki S, Lohmann K, Klein C. 2010. Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients. Hum Mol Genet 19:3124-3137.
68. Rehling P, Wiedemann N, Pfanner N, Truscott KN. 2001. The mitochondrial import machinery for preproteins. Crit Rev Biochem Mol Biol 36:291-336.
69. Ries V, Henchcliffe C, Kareva T, Rzhetskaya M, Bland R, During MJ, Kholodilov N, Burke RE. 2006. Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease. Proc Natl Acad Sci U S A 103:18757-18762.
70. Roise D, Theiler F, Horvath SJ, Tomich JM, Richards JH, Allison DS, Schatz G. 1988. Amphiphilicity is essential for mitochondrial presequence function. EMBO J 7:649-653.
71. Saunders NF, Brinkworth RI, Huber T, Kemp BE, Kobe B. 2008. Predikin and PredikinDB: a computational framework for the prediction of protein kinase peptide specificity and an associated database of phosphorylation sites. BMC Bioinformatics 9:245.
72. Schmidt O, Pfanner N, Meisinger C. 2010. Mitochondrial protein import: from proteomics to functional mechanisms. Nat Rev Mol Cell Biol 11:655-667.
73. Schneider G, Sjoling S, Wallin E, Wrede P, Glaser E, von Heijne G. 1998. Feature-extraction from endopeptidase cleavage sites in mitochondrial targeting peptides. Proteins 30:49-60.
74. Sha D, Chin LS, Li L. 2010. Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling. Hum Mol Genet 19:352-363.
75. Shi G, Lee JR, Grimes DA, Racacho L, Ye D, Yang H, Ross OA, Farrer M, McQuibban GA, Bulman DE. 2011a. Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease. Hum Mol Genet 20:1966-1974.
76. Shi SP, Qiu JD, Sun XY, Huang JH, Huang SY, Suo SB, Liang RP, Zhang L. 2011b. Identify submitochondria and subchloroplast locations with pseudo amino acid composition: approach from the strategy of discrete wavelet transform feature extraction. Biochim Biophys Acta 1813:424-430.
77. Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, Valente EM, Casari G. 2005. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14:3477-3492.
78. Sim CH, Lio DS, Mok SS, Masters CL, Hill AF, Culvenor JG, Cheng HC. 2006. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum Mol Genet 15:3251-3262.
79. Steinberg RA, Cauthron RD, Symcox MM, Shuntoh H. 1993. Autoactivation of catalytic (C alpha) subunit of cyclic AMP-dependent protein kinase by phosphorylation of threonine 197. Mol Cell Biol 13:2332-2341.
80. Takatori S, Ito G, Iwatsubo T. 2008. Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1. Neurosci Lett 430:13-17.
81. Taylor SS, Knighton DR, Zheng J, Ten Eyck LF, Sowadski JM. 1992. Structural framework for the protein kinase family. Annu Rev Cell Biol 8:429-462.
82. Turk BE. 2008. Understanding and exploiting substrate recognition by protein kinases. Curr Opin Chem Biol 12:4-10.
83. Turk BE, Hutti JE, Cantley LC. 2006. Determining protein kinase substrate specificity by parallel solution-phase assay of large numbers of peptide substrates. Nat Protoc 1:375-379.
84. Tusnady GE, Simon I. 1998. Principles governing amino acid composition of integral membrane proteins: application to topology prediction. J Mol Biol 283:489-506.
85. Tusnady GE, Simon I. 2001. The HMMTOP transmembrane topology prediction server. Bioinformatics 17:849-850.
86. Ubersax JA, Ferrell JE Jr. 2007. Mechanisms of specificity in protein phosphorylation. Nat Rev Mol Cell Biol 8:530-541.
87. Urban S, Freeman M. 2003. Substrate specificity of rhomboid intramembrane proteases is governed by helix-breaking residues in the substrate transmembrane domain. Mol Cell 11:1425-1434.
88. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, et al. 2004. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:1158-1160.
89. van Geest M, Lolkema JS. 2000. Membrane topology and insertion of membrane proteins: search for topogenic signals. Microbiol Mol Biol Rev 64:13-33.
90. Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, May J, Tocilescu MA, Liu W, Ko HS, Magrane J, Moore DL, et al. 2010. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 107:378-383.
91. von Heijne G. 1992. Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J Mol Biol 225:487-494.
92. von Heijne G. 1995. Membrane protein assembly: rules of the game. Bioessays 17:25-30.
93. von Heijne G. 2006. Membrane-protein topology. Nat Rev Mol Cell Biol 7:909-918.
94. von Heijne G, Steppuhn J, Herrmann RG. 1989. Domain structure of mitochondrial and chloroplast targeting peptides. Eur J Biochem 180:535-545.
95. Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, Selkoe D, Rice S, Steen J, LaVoie MJ, Schwarz TL. 2011. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147:893-906.
96. Weihofen A, Ostaszewski B, Minami Y, Selkoe DJ. 2008. Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1. Hum Mol Genet 17:602-616.
97. Weihofen A, Thomas KJ, Ostaszewski BL, Cookson MR, Selkoe DJ. 2009. Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry 48:2045-2052.
98. Woodroof HI, Pogson JH, Begley M, Cantley LC, Deak M, Campbell DG, van Aalten DMF, Whitworth AJ, Alessi DR, Muqit MMK. 2011. Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutations. Open Biology 1:110012.
99. Xiong H, Wang D, Chen L, Choo YS, Ma H, Tang C, Xia K, Jiang W, Ronai Z, Zhuang X, Zhang Z. 2009. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest 119:650-660.
100. Yang Y, Lu B. 2009. Mitochondrial morphogenesis, distribution, and Parkinson disease: insights from PINK1. J Neuropathol Exp Neurol 68:953-963.
101. Yoshii SR, Kishi C, Ishihara N, Mizushima N. 2011. Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem 286:19630-19640.
102. Youle RJ, Narendra DP. 2011. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12:9-14.
103. Zhang F, Strand A, Robbins D, Cobb MH, Goldsmith EJ. 1994. Atomic structure of the MAP kinase ERK2 at 2.3 A resolution. Nature 367:704-711.
104. Zheng J, Knighton DR, ten Eyck LF, Karlsson R, Xuong N, Taylor SS, Sowadski JM. 1993a. Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor. Biochemistry 32:2154-2161.
105. Zheng J, Trafny EA, Knighton DR, Xuong NH, Taylor SS, Ten Eyck LF, Sowadski JM. 1993b. 2.2 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor. Acta Crystallogr D Biol Crystallogr 49:362-365.
106. Zhou C, Huang Y, Shao Y, May J, Prou D, Perier C, Dauer W, Schon EA, Przedborski S. 2008. The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc Natl Acad Sci U S A 105:12022-12027.